CHIRURGIA, vol.110, no.1, pp.49-55, 2015 (ESCI)
Background/Objectives: To evaluate the harmful effects of 5-floururacil (5-FU) and Irinotecan on the liver and to determine the role of Pioglitazone in averting liver damage.